Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tumor necrosis factor receptor superfamily member 1A (TNFR1) extracellular domain, Peptidoglycan recognition protein 1 (Tag7)–Heat shock protein 70 (Hsp70) complex is a specialized molecular assembly that plays a critical role in the innate immune system's ability to eliminate tumor cells (Sashchenko et al., 2004). This complex consists of a stable heterodimer of Tag7 (PGLYRP1) and Hsp70, which functions as a specific ligand for the extracellular domain of the TNFR1 receptor (Dukhanina et al., 2015). Unlike the primary ligand TNF-alpha, which often activates the NF-kappaB survival pathway, the Tag7–Hsp70 complex is reported to selectively induce apoptosis via the activation of Caspase-8 and the mitochondrial pathway (Yashin et al., 2016). This selective pro-apoptotic activity makes the complex a significant subject of research for cancer therapeutics, particularly for treating tumors that have acquired resistance to conventional TNF-alpha-mediated cytotoxicity (Dukhanina et al., 2015). The interaction is highly specific to the TNFR1 extracellular domain, and the complex is naturally secreted by cytotoxic lymphocytes during the immune response against cancer (Sashchenko et al., 2004).
The Tag7-Hsp70 complex acts as an agonistic ligand that binds to the extracellular domain of TNFR1, specifically triggering Caspase-8 activation and the mitochondrial apoptotic pathway without activating the NF-kappaB survival pathway (Sashchenko et al., 2004; Dukhanina et al., 2015).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor receptor superfamily member 1A (TNFR1) extracellular domain, Peptidoglycan recognition protein 1 (Tag7)–Heat shock protein 70 (Hsp70) complex (TNFR1-Tag7-Hsp70).